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Identification of the Abl- and rasGAP-Associated
62 kDa Protein as a Docking Protein, Dok
Yuji Yamanashi*² and David Baltimore* rasGAP. Carpino et al. (1996 [this issue of Cell]) have
also found the equivalent human protein.*Department of Biology
Massachusetts Institute of Technology
Cambridge, Massachusetts 02139 Results and Discussion
² Institute of Medical Science
University of Tokyo To isolate p62, we used the v-abl-transformed murine
Minato-ku, Tokyo-108 precursor B cell line 1±2 as starting material. When the
Japan proteins of this cell were separated by electrophoresis,
staining of the gel with anti-phosphotyrosine antibody
showed that the major tyrosine-phosphorylated protein
was a doublet, p62/64 (Figure 1A). Therefore, all of theSummary
tyrosine-phosphorylated proteins from 5 3 1010 1±2 cells
were purified together using the anti-phosphotyrosineA 62 kDa protein is highly phosphorylated in many
monoclonal antibody, PY20, conjugated to agarose.cells containing activated tyrosine kinases. This pro-
Coomassie blue±staining of a gel inwhich these proteinstein, characterized mainly by its avid association with
were fractionated showed clear bands of p160v-abl andrasGAP, has proved elusive. Anti-phosphotyrosine an-
other probable breakdown products but only an indis-tibody was used to purify p62. From peptide sequence,
tinct p62/64 (Figure 1B). Apparently, p62/64 is muchmolecular cloning revealed a cDNA encoding a novel
more heavily tyrosine-phosphorylated than v-Abl and isprotein, p62dok, with little homology to others but with
therefore quite evident by anti-phosphotyrosine staininga prominent set of tyrosines and nearby sequences
but not by protein staining. The indistinct bands of p62suggestive of SH2 binding sites. In cells, v-Abl tyrosine
and p64 were excised from gels (about 8 mg of p62kinase binds and strongly phosphorylates p62dok,
and 3 mg of p64), and the proteins were cleaved withwhich thenbinds rasGAP. A monoclonal antibody, 2C4,
lysylendopeptidase in the gel, eluted, and subjected toto the rasGAP-associated p62 reacts with p62dok. Thus,
HPLC purification. The cleavage patterns of these twop62dok appears to be the long-sought major substrate
proteins were virtually the same as judged by the HPLCof many tyrosine kinases.
elution profiles (Y. Y. and D. B., unpublished data), sug-
gesting that p64 is an alternatively modified form of p62.
The HPLC-purified fragments of p62 were subjectedIntroduction
to micropeptide sequencing to obtain six independent
peptide sequences (underlined in Figure 2A). Degener-A 62 kDa protein (p62) that is associated with the p120
Ras GTPase activating protein (rasGAP) was originally ate primers representing sequences ALAQTENQP of
peptide II and KVGQAQDIL of peptide IV were used toidentified as a common target of protein±tyrosine ki-
nases v-Abl, v-Src, v-Fps, v-Fms, and activated EGF amplify a cDNA from 1±2 cell RNA by polymerase chain
reaction (PCR), producing a 422 base pair (bp) cDNA.receptor (Ellis et al., 1990). Tyrosine phosphorylation
of p62 correlates with transforming activity of the viral Nucleotide sequence revealed an open reading frame
encoding peptides II, IV, and III (Figure 2A), indicatingoncogene products as well as Bcr-Abl, a causative tyro-
sine kinase of human chronic myelogenous leukemia that it is a partial cDNA of p62. Screening of a mouse
spleen cDNA library yielded a clone with a 1749 bp insert(Koch et al., 1989; Moran et al., 1990; Bouton et al.,
1991; Muller et al., 1991; DeClue et al., 1993; Parmar containing 1446 bp of open reading frame (ORF) initi-
ated at an ATG codon fitting the Kozak consensusand Rosenberg, 1996). A p62 is also rapidly tyrosine-
phosphorylated upon PDGF-, CSF-1-, Insulin-, IGF-, and (GCCATGG) (Kozak, 1986). The 482 amino acid se-
quence of the deduced protein product had all six pep-VEGF-stimulation of cells (Heidaran et al., 1992; Hosomi
et al., 1994; Guo et al., 1995; Sanchez-Margalet et al., tide sequences from purified p62 (Figure 2A). Although
the length of 482 amino acids is less than might be1995). Stimulation of B cell receptors or Fcg receptors
(type IIIA; CD16), both of which are coupled with cyto- expected for a 62 kDa protein, the tyrosine-phosphory-
lated product translated from the cDNA comigrates withsolic tyrosine kinases, also induces tyrosine phosphory-
lation of a p62 (Gold et al., 1993; Darby et al., 1994). the endogenous tyrosine-phosphorylated p62 of 1±2
cells (see Figure 3B). Thus, the cDNA probably containsAssuming that all of these are the same p62, these data
strongly suggest that p62 plays a central role in signaling the entire coding region of p62 mRNA. Since the de-
duced amino acid sequence of p62 does not matchmediated by a wide range of tyrosine kinases. However,
characterization of p62 has awaited molecular cloning. any known protein sequence, we designate the novel
genetic locus for p62 the dok gene (downstream of tyro-A cDNA reported to encode rasGAP-associated p62
turned out to encode Sam68, a protein distinct from p62 sine kinases).
By Northern blot analysis with a mouse multiple-tissuethat is a substrate of tyrosine kinases (Wong et al., 1992;
Fumagalli et al., 1994; Taylor and Shalloway, 1994; Lock blot, only a 1.9 kb dok mRNA was detected (Figure 2B).
This agreed with the sizeof ourclone, assuming a poly(A)et al., 1996). Here, we report cloning of a cDNA encoding
mouse p62. The protein, p62dok, is tyrosine-phosphory- tail of about 100±200 bases. Expression of the gene is
widespread, except in brain and testis.lated when coexpressed with Abl and then binds to
Cell
206
al., 1996). An entire PTB domain is not evident from
the sequence, and PTB domains are structurally close
relatives of PH domains (Zhou et al., 1995; Eck et al.,
1996; Harrison, 1996; Lemmon et al., 1996), making it
uncertain whether this homology suggests that p62dok
can interact with other phosphotyrosine-containing pro-
teins. p62dok has several potential target sites for serine/
threonine kinases such as PKC (S14, T25, S331), MAPK
(S33, S147), CK-II (T274), and Cdk2 (S415) but has no
apparent myristoylation or palmitylation sites. Overall,
the protein is relatively rich in serines and threonines
(15%). A C-terminal 145 amino acid stretch (P280 to
P424) is very rich in proline residues (21.4%), while the
rest of the protein has relatively few (4.4%).
Songyang, Cantley, and their colleagues have defined
the peptide sequences that are preferential substrates
of many tyrosine kinases (Songyang et al., 1995). In
general, cytosolic kinases like Abl and Src selectively
phosphorylate peptides of the form (I/V/L)±Y±(G/A/S/
E/D), while receptor kinases phosphorylate ones like
(E/D)±Y±(F/V/I/M). In p62dok, there are several apparent
target sites for cytosolic kinases but not ones for recep-
tor kinases (Figure 2A). This is consistent with the obser-
vation that rasGAP-associated p62 is phosphorylated
in cells with activated cytosolic kinases such as v-Src
and v-Abl and suggests that the protein is a direct sub-
strate of the kinases. Upon cell surface±receptor±
mediated signaling, p62dok may be phosphorylated byFigure 1. Purification of Phosphotyrosine-Containing Proteins from
cytosolic kinases recruited by receptor tyrosine kinases1±2 Precursor B Cells
or by antigen or Fcg receptors. Seven of the eight char-(A) Phosphotyrosine-containing proteins in 1±2 cells. 1±2 cells were
solubilized with TNN buffer, and the lysate from 4 3 105 cells were acterized putative primary phosphorylation sites for cy-
subjected to immunoblot analysis with anti-phosphotyrosine an- tosolic kinases also represent SH2 binding motifs for
tibody. the kinases (Figure 2A) (Songyang et al., 1993; Songyang
(B) Phosphotyrosine-containing proteins purified from 1±2 cells.
et al., 1995). This suggests that once phosphorylated,Proteins purified from 1 3 109 1±2 cells (1±2) and 0.1 mg of bovine
p62dok can be further phosphorylated on multiple tyro-serum albumin (BSA) were subjected to SDS±PAGE and to Coomas-
sine residues in complex with a cytosolic tyrosine kinasesie blue staining.
Positions of p160v-abl and 62/64 kDa protein, and positions and sizes as proposed in the ªprocessive phosphorylationº model
(kDa) of standard protein markers are indicated. for Abl phosphorylation of p130Cas (Mayer et al., 1995;
Pawson, 1995). This could explain the prominent tyro-
sine phosphorylation of p62dok upon tyrosine kinase±
Although database searches found no striking homol- mediated signaling.
ogy to known proteins in thep62dok sequence, two partial The previous suggestion that the rasGAP±SH2 do-
homologies were detected. One is a potential PH (pleck- main directly binds to tyrosine-phosphorylated p62dok
strin homology) domain at the N terminus detected by implies the existence of a rasGAP±SH2 target site of the
a profile search (previously noted in human Dok by Car- form pYxxP (Mayer et al., 1992; Songyang et al., 1993)
pino et al. (1996; see adjoining paper) (Figure 2A). PH (Z. Songyang, personal communication). Among the 15
domains may be involved in the membrane localization tyrosine residues in p62dok, six have the requisite proline
of proteins (Lemmon et al., 1996). The second is a short at 13 (Figure 2A). pYxxP is also a preferential target site
homology between p62dok and insulin receptor sub- for the SH2 domains of Abl and Crk (Songyang et al.,
strate-1 (IRS-1) detected by a BLAST search (Sun et al., 1993). Moreover, p62dok has other potential SH2 target
1991). It covers part of the PTB domain of IRS-1 (Figure sites (Figure 2A). All except one (Y340GHV/mouse to
2C), which binds phosphotyrosine-containing motifs of Y341EHA/human) of these SH2 target sites are conserved
the form NPXpY (He et al., 1995; Wolf et al., 1995; Eck 100% in human Dok (see adjoining paper, Carpino et
et al., 1996; Harrison, 1996). The PTB-like sequence of al., 1996). Thus, p62dok may function as a docking protein
mouse Dok is conserved 100% in human Dok, whereas for tyrosine kinase±mediated signaling, as proposed for
overall amino acid identity between mouse and human IRS-1 upon insulin stimulation (Myers et al., 1994).
Dok is 83% (see adjoining paper, Carpino et al., 1996). Multiply tyrosine-phosphorylated p62dok might recruit
In addition, a similar sequence was found in peptide SH2-containing signaling molecules to the membrane
sequences encoded by mouse and human EST (ex- fraction of cells, where the rasGAP±p62dok complex is
pressed sequence tag) cDNA clones, AA008417 and preferentially localized (Moran et al., 1991). It has been
T09328 (Figure 2C). Interestingly, the two arginine resi- suggested that only 10±25% of tyrosine-phosphorylated
dues of IRS-1, which interact directly with the phospho- p62dok is associated with rasGAP (Bouton et al., 1991;
Moran et al., 1991) and that phospholipase C-g1 andtyrosine, are conserved in p62dok and the ESTs (Eck et
Abl- and rasGAP-Associated p62dok
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Figure 2. Deduced Amino Acid Sequence of p62dok and the dok Gene Expression
(A) Deduced amino acid sequence of p62dok. The peptide sequences obtained by microsequencing are underlined (I±VI). The potential PH
domain is indicated by the dashed box. The 29 residues (L206 to Q234) weakly homologous to the IRS-1 PTB domain are indicated by dashed
line (see Figure 2C). Potential phosphorylation sites of cytosolic tyrosine kinases are indicated by closed ellipse. Potential SH2 binding sites
are boxed. These are: YxxP for Abl, rasGAP, and Crk; YxxV for Src family and SHPTP2; YTLL for Shb, Zap70, and SHPTP2; YWDL for SHPTP1;
and YDEP for Nck.
(B) Northern blot analysis of the dok gene. A Northern blot containing poly(A)1 RNA from mouse multiple tissues was hybridized with the dok
cDNA probe (top) or b-actin cDNA probe as a control (bottom). Positions of the dok mRNA and b-actin mRNAs (2.0 and 1.8 kb), and positions
and sizes (kb) of standard nucleotide markers are indicated (top).
Lanes: He, Heart; Br, Brain; Sp, Spleen; Lu, Lung; Li, Liver; Sm, Skeletal muscle; Ki, Kidney; Te, Testis.
(C) Sequence alignment of the 29 amino acids of p62dok and IRS-1. The 29 amino acids of mouse p62dok (L206 to Q234) and mouse IRS-1 (I206
to Q234), or p62dok and corresponding sequence encoded by mouse EST cDNA AA008417 or human EST cDNA T09328 are aligned. Two
arginine residues of IRS-1, which directly interact with phosphotyrosine, are indicated by closed arrows. Amino acids contributing three
b-sheet strands ([b5], [b6], and [b7]) of the IRS-1 PTB domain are boxed (Eck et al., 1996). Identical and similar (1) residues in each alignment
are indicated.
p50csk may also be associated with p62dok, probably (Duyster et al., 1995; Mayer et al., 1995; Pawson, 1995).
These data strongly suggest that p62dok is directly andthrough their SH2 (Maa et al., 1994; Neet and Hunter,
1995). multiply phosphorylated by v-Abl in vivo. To our sur-
prise, p62dok is also highly tyrosine-phosphorylatedTo study the interaction of p62dok with rasGAP, we
performed a transient expression assay using 293 cells when coexpressed with exogenous c-Abl, although
c-Abl does not autophosphorylate (Figure 3A). Theseas recipient. First, we verified that p62dok gets phos-
phorylated by v-Abl. As expected, both p62dok and data with overexpressed c-Abl might imply a role of
p62dok in the normal function of Abl kinase, but furtherinfluenza hemagglutinin±epitope±tagged (HA-tagged)
p62dok were heavily tyrosine-phosphorylated when coex- examination of this question is needed.
rasGAP-associated p62 has previously been con-pressed with v-Abl (Figure 3A). The phosphorylated form
of p62dok and HA-tagged p62dok migrated at 62/64 kDa fused with the Sam68 protein (Lock et al., 1996). Roth
and his colleagues raised a monoclonal antibody, 2C4,and p63/65 kDa, respectively (Figure 3A). The 62/64 kDa
doublet of phosphorylated p62dok from transfected 293 against the p62 and separated it from Sam68 (Hosomi
et al., 1994; Ogawa et al., 1994; Neet and Hunter, 1995).cells comigrated with the tyrosine-phosphorylated 62/
64 kDa doublet of endogenous p62dok from 1±2 cells 2C4 recognizes tyrosine-phosphorylated p62, at least
in v-src-transformed cells and in insulin-stimulated cells.(Figure 3B). The unphosphorylated form of HA-tagged
p62dok migrated at about 61 kDa, indicating that tyrosine To ascertain whether the protein recognized by 2C4 was
the same one as ours, we obtained the antibody andphosphorylation of p62dok causes a mobility shift and
also that nearly 100% of the HA-tagged p62dok is phos- used it to immunoprecipitate p62dok. It precipitated HA-
tagged p62dok, whereas monoclonal antibody to Sam68phorylated by v-Abl (Figure 3A). Furthermore, v-Abl is
coprecipitated with HA-tagged p62dok, indicating that did not (Figure 3D). This indicates that the rasGAP-asso-
ciated p62 in v-src-transformed cells and in insulin-stim-v-Abl forms a stable complex with p62dok in vivo (Figure
3C), as suggested previously (Mayer et al., 1992) and ulated cells is p62dok or its immunologically related pro-
tein. In fact, p62dok was heavily tyrosine-phosphorylatedpredicted by the processive phosphorylation model
Cell
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Figure 3. Tyrosine Phosphorylation of p62dok by v-Abl and Its Interaction with p120 rasGAP
(A) Tyrosine phosphorylation of p62dok by Abl kinase. The lysates from 1 3 105 293 cells transfected with various combinations of expression
plasmids of v-abl (v), c-abl (c), p62dok, HA-tagged p62dok (HA±Dok), or mock control (2) were subjected to immunoblot analysis probed with
anti-phosphotyrosine antibody (top), anti-Abl antibody (middle), or anti-HA epitope antibody (bottom). Positions of v-Abl, c-Abl, p62dok, and
HA-tagged p62dok are indicated. Positions and sizes (kDa) of standard protein markers are indicated (top).
(B) The lysate from 3 3 104 293 cells transfected with expression plasmids of p62dok (Dok) and v-abl (v-Abl) and the lysate from 3 3 105 1±2
cells (1±2) were subjected to immunoblot analysis with anti-phosphotyrosine antibody. Position of p62dok is indicated.
(C) The lysates from 1.5 3 106 293 cells transfected with expression plasmids of v-abl (v), HA-tagged p62dok (HA±Dok), and mock control (2)
were subjected to immunoprecipitation with anti-HA epitope antibody (a-HA[IP]). The immune complexes were subjected to immunoblot
analysis with anti-Abl antibody (top). 1/15 of the same lysates were subjected to immunoblot analysis with anti-Abl (middle) or anti-HA epitope
antibody (bottom). Positions of v-Abl, HA-tagged p62dok, and the heavy chain of anti-HA epitope antibody (Ig) are indicated. Positions and
sizes (kDa) of standard protein markers are indicated (top).
(D) The lysates from 1.5 3 106 293 cells transfected with a expression plasmid of HA-tagged p62dok (HA±Dok) or mock control (2) were
subjected to immunoprecipitation with 2C4 monoclonal antibody (2C4) or anti-Sam68 (a-Sam) antibody.The immune complexes were subjected
to immunoblot analysis with anti-HA epitope antibody. Positions of HA-tagged p62dok and the heavy chain of 2C4 or anti-Sam68 antibody (Ig)
are indicated. Positions and sizes (kDa) of standard protein markers are indicated.
(E) The lysates from 1.5 3 106 293 cells transfected with expression plasmids of v-abl (v), HA-tagged p62dok (HA±Dok), or mock control (2)
were subjected to immunoprecipitation with anti-HA epitope antibody. The immune complexes were subjected to immunoblot analysis with
anti-rasGAP antibody (top). 1/15 of the same lysates were subjected to immunoblot analysis with anti-rasGAP antibody (bottom). Positions
of rasGAP and the heavy chain of anti-HA epitope antibody (Ig) are indicated. Positions and sizes (kDa) of standard protein markers are
indicated (top).
(F) The lysates from 1 3 106 293 cells transfected with expression plasmids of p62dok and v-abl are incubated with rasGAP N-terminal SH2 or
SH3 domains fused with GST. The proteins bound with the fusion proteins were subjected to immunoblot analysis with anti-phosphotyrosine
antibody. The position of p62dok is indicated.
when coexpressed with v-Src in 293 cells (Y. Y and D. B., only the tyrosine-phosphorylated form of p62dok can as-
sociate with rasGAP in vivo. In addition, tyrosine-phos-unpublished data).
Next, we examined whether p120 rasGAP forms a phorylated p62dok was bound in vitro to the N-terminal
SH2 of rasGAP fused with glutathione S-transferasestable complex with p62dok. Endogenous rasGAP of 293
cells was efficiently coimmunoprecipitated with HA- (GST) but not to its SH3 fusion protein (Figure 3F).
Thatmice lacking p120 rasGAP show vascular defectstagged p62dok when coexpressed with v-Abl (Figure 3E).
However, rasGAP was not coimmunoprecipitated with and aberrant apoptosis of neural cells underscores the
physiological significance of the protein (Henkemeyerp62dok without expression of v-Abl. This indicates that
Abl- and rasGAP-Associated p62dok
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et al., 1995). Recently, Parmar and Rosenberg reported partners. How these many adapter and docking proteins
act in the cellular economy is uncertain, but the knowl-that the lymphoid-transforming activity of v-abl variants
that do not induce either tyrosine phosphorylation of edge that cytoplasmic tyrosine kinases have such dock-
ing proteins as major substrates suggests that they arep62dok or rasGAP is restored by coexpression of v-ras
(Parmar and Rosenberg, 1996). This suggests that p62dok a key to understanding both the normal and oncogenic
activities of these kinases.and/or rasGAP could be a link between v-Abl and the
Ras pathway, one that is essential in tyrosine kinase±
Experimental Proceduresmediated signaling. Because rasGAP is a negative regu-
lator of Ras and transient expression of Bcr-Abl down-
Cell Culture and Monoclonal Antibodiesmodulates cellular rasGAP activity (Skorski et al., 1994),
1±2, a v-abl-transformed precursor B cell line established from bone
binding of p62dok to rasGAP may inactivate it or tether marrow cells of Rag-12/2 mice, was a gift from C. Roman and was
it away from Ras. Alternatively, p62dok may act to connect maintained in RPMI-1640 medium supplemented with 10% fetal calf
tyrosine kinases and rasGAP by making a ternary com- serum. The human kidney cell line, 293, was grown in Dulbecco's
modified Eagle's medium containing 10% fetal calf serum. Theplex, v-Abl±p62dok±rasGAP, in which tyrosine phosphor-
monoclonal antibody, 2C4, to the rasGAP-associated p62 was a giftylation of rasGAP can occur. This could inactivate ras-
from R. Roth. The anti-Abl (24±11) and the anti-p120 rasGAP (B4F8)GAP (or could activate a hypothetical effector activity
monoclonal antibodies were purchased from Santacruz Biotechnol-
of rasGAP in the Ras pathway [Boguski and McCormick, ogy. The anti-phosphotyrosine monoclonal antibody, PY20, and
1993]). However, it is also possible that p62dok recruits an PY20-conjugated agarose werepurchased from Transduction Labo-
active rasGAP to serve directly as a negative regulator ratory. The monoclonal antibody, 12CA5, was used to detect HA
epitope.of Ras.
These data show that the p62 that interacts with Abl,
Purification of 62/64 kDa Protein and Peptide SequencingSrc, and rasGAP is a single entity, p62dok. Presumably,
1.7 3 1010 1±2 cells were solubilized with 170 ml of TNN buffer
the other tyrosine kinases that heavily phosphorylate a (50 mM Tris [pH 8.0], 150 mM NaCl, 1% NP-40, 0.2 mM sodium
p62 also target this molecule. The best evidence for this orthovanadate, aprotinin [20 mg/ml]), and the lysate was cleared by
is that the 2C4 antibody (Hosomi et al., 1994; Ogawa et centrifugation. The cleared lysate was incubated at 48C for 16 hr
with 2.5 mg of PY20 anti-phosphotyrosine monoclonal antibodyal., 1994), which is known to react with a target of v-Src
conjugated to agarose. The slurry was washed extensively with TNNand insulin receptor, reacts with p62dok.
buffer and SDS-washing buffer (50 mM Tris [pH 8.0], 150 mM NaCl,Dok is a member of an increasingly large class of
1 mM EDTA, 1 % NP-40, 1% SDS, 0.2 mM sodium orthovanadate,
ªdockingº proteins that are not related by extensive se- aprotinin [20 mg/ml]), and phosphotyrosine-containing proteins were
quence identities but that have the same general fea- eluted by boiling with 1 ml of elution buffer (100 mM Tris [pH 6.8], 1%
tures. They contain multiple tyrosine residues that are in SDS). The eluted protein was concentrated by membrane filtration
(Vivaspin-500 [Vivascience, UK]). The concentrated protein was pre-sequence environments suggestive of their being kinase
cipitated with 4.5 vol of acetone to get rid of excess SDS, thensubstrates and SH2 binding sites. They also may contain
solubilized in 40 ml of SDS loading buffer. Three replicate prepara-proline-rich regions and serine/threonine±rich areas that
tions were made. From one, 2.5 ml was subjected to analytical SDS/
are suggestive of sites for interaction with other motifs 8.5% PAGE (see Figure 1B). The rest of the samples were then
inpotential partner proteins. Furthermore, they may con- subjected to SDS/8.5% PAGE and stained with Coomassie blue to
tain lipid/protein±binding motifs, such as the PH and locate p62 and p64. The piece of gel with the protein was excised
and digested with lysylendopeptidase. The peptides were elutedthe PTB domains of IRS-1 or the SH3 domain of Cas,
from the gel fragment and separated by HPLC. Peptides separatedthrough which they could bind to sites on partners (per-
from p62 were subjected to standard micropeptide sequencing, andhaps the PH-like or the PTB-like domains in Dok are
six independent peptide sequences were assigned.
such domains). The first such protein was IRS-1, but
now there are many others, including IRS-2, Cas, Sin/ cDNA Cloning
Efs, and Gab1 (Sun et al., 1991; Sakai et al., 1994; Ishino PCR was performed with the primers 59-GCIITIGCICA(A/G)ACIGA
A(A/G)AA(T/C)CA(A/G)CC-39 and 59-AGIATITC(T/C)CTGIGC(T/C)TGIet al., 1995; Sun et al., 1995; Alexandropoulos and Balti-
CCNAC(T/C)TT-39, AmpliTaqGold polymerase (Perkin Elmer), and 1more, 1996; Holgado et al., 1996). IRS-1-deficient mice
mg of template cDNA prepared from 1±2 cells, using 43 amplificationshowed impaired biological responses to insulin and
cycles (958C for 30 s, 588C for 10 s, 1 min ramp to 728C, 728C for
IGF-1 stimulation (Araki et al., 1994; Tamemoto et al., 10 s), producing a 422 bp cDNA. Using this PCR product as a
1994). probe, 3 3 106 plaques prepared from mouse spleen cDNA library
The various known docking proteins contain putative (Stratagene) were screened to obtain 12 independent positive
clones. Of the 12 clones, four clones had a cDNA insert longer thanSH2 binding sites of variable specificity. For instance,
1700 bp, the longest being 1749 bp.IRS-1 and IRS-2 contain many YxxM motifs, the target
site of the PI-3 kinase SH2, whereas Cas, Sin/Efs, and
Northern Blot AnalysisDok contain many YxxP motifs but none of the form
A mouse multiple-tissue Northern blot filter carrying 2 mg of poly(A)1
YxxM. Although YxxP is a potential target site of Crk RNA from each tissue (Clonetech) was probed with the 422 bp cDNA
SH2, tyrosine-phosphorylated Dok did not detectably of the dok gene prepared by PCR (see above), or human b-actin
bind Crk (Y. Y. and D. B., unpublished data). Both phos- cDNA (Clonetech) under high stringency conditions according to
the instructions of the manufacturer.phorylated Cas and Sin/Efs do bind Crk (Sakai et al.,
1994; Alexandropoulos and Baltimore, 1996). These
Expression Plasmidsfindings suggest that each docking protein may have the
p160v-abl and p140c-abl (type IV) expression plasmids, pGD-v-abl and
specificity to recruit a particular set of SH2-containing pPLcIV, respectively, were generated as described (Jackson and
proteins to induce appropriate biological responses. Baltimore, 1989; Scott et al., 1991). The dok cDNA containing an
The ªadapterº proteins like Crk are related entities, entire coding region was inserted into the MSCV expression plasmid
in appropriate orientation to generate MSCV±Dok (Hawley et al.,presumably serving as integrators by binding of multiple
Cell
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1994). The cDNA encoding HA-tagged p62dok was generated by in- Boguski, M.S., and McCormick, F. (1993). Proteins regulating Ras
and its relatives. Nature 366, 643±654.troducing the HA epitope sequence between the first and second
codons of the ORF of the dok cDNA by using PCR as follows. The Bouton, A.H., Kanner, S.B., Vines, R.R., Wang, H.C., Gibbs, J.B.,
HA-tagged p62dok cDNA was amplified by PCR with primers and Parsons, J.T. (1991). Transformation by pp60src or stimulation
59-GCCATGGCTTACCCATACGATGTTCCAGATTACGCTGACGGGGC of cells with epidermal growth factor induces the stable association
TGTGATGGAGGGTCCG-39 and 59-CCCACTCAGACCAGTGGGCCG of tyrosine-phosphorylated cellular proteins with GTPase-activating
CTTC-39, Pfu polymerase (Stratagene), and 0.1 mg of template dok protein. Mol. Cell Biol. 11, 945±953.
cDNA, using 25 amplification cycles (948C for 30 s, 558Cfor 30 s, 728C Darby, C., Geahlen, R.L., and Schreiber, A.D. (1994). Stimulation
for 15 min). The PCR product was inserted into MSCV expression of macrophage Fc gamma RIIIA activates the receptor-associated
plasmid (Hawley et al., 1994) in appropriate orientation to generate protein tyrosine kinase Syk and induces phosphorylation of multiple
MSCV±HA±Dok. proteins including p95Vav and p62/GAP-associated protein. J. Im-
munol. 152, 5429±37.
Transfection, Immunoblot Analysis, Immunoprecipitation, DeClue, J.E., Vass, W.C., Johnson, M.R., Stacey, D.W., and Lowy,
and GST-Fusion Protein Binding Assay D.R. (1993). Functional role of GTPase-activating protein in cell
2 3 106 293 cells were seeded into 60 mm dishes and transfected transformation by pp60v-src. Mol. Cell Biol. 13, 6799±6809.
the next day with various combinations of 7.5 mg of expression Duyster, J., Baskaran, R., and Wang, J.Y. (1995). Src homology 2
plasmids, pGD-v-abl, pPLcIV, MSCV±Dok and MSCV±HA±Dok, re- domain as a specificity determinant in the c-Abl±mediated tyrosine
spectively, by the standard calcium phosphate method. After incu- phosphorylation of the RNA polymerase II carboxyl-terminal re-
bation for two days, cells were washed with phosphate-buffered peated domain. Proc. Natl. Acad. Sci. USA 92, 1555±1559.
saline and then solubilized with 750 ml of TNN buffer. Five or fifteen
Eck, M.J., Dhe, P.S., Trub, T., Nolte, R.T., and Shoelson, S.E. (1996).
ml of the lysates were resolved by SDS/8.5% PAGE and transferred
Structure of the IRS-1 PTB domain bound to the juxtamembraneto a polyvinylidene difluoride membrane (Bio-Rad). The blot was
region of the insulin receptor. Cell 85, 695±705.probed with monoclonal antibody to Abl, HA epitope, or phosphoty-
Ellis, C., Moran, M., McCormick, F., and Pawson, T. (1990). Phos-rosine. The antibody was visualized with horseradish peroxidase±
phorylation of GAP and GAP-associated proteins by transformingcoupled goat anti-mouse immunoglobulin (Santacruz Biotechnol-
and mitogenic tyrosine kinases. Nature 343, 377±81.ogy) using the Enhanced Chemiluminescence Western Blotting
Detection System (Amersham) according to the instructions of the Fumagalli, S., Totty, N.F., Hsuan, J.J., and Courtneidge, S.A. (1994).
manufacturer. A target for Src in mitosis. Nature 368, 871±874.
For immunoprecipitation, 200±300 ml of the lysates prepared from Gold, M.R., Crowley, M.T., Martin, G.A., McCormick, F., and De-
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